Stocks
Gilead Sciences (GILD) EBITDA margin US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 34.5% | 34.6% | 24.8% | 38.1% | 43.2% | 39.3% | ||
| Changes by years, y/y, % | +7pp | +0pp | -10pp | +13pp | +5pp | +1.5% | |||
Gilead Sciences. EBITDA margin, %
Gilead Sciences. EBITDA margin, changes, pp
Gilead Sciences (GILD) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | 2024Q1 | LTM ? | |||
| EBITDA margin, % | ? | 37.5% | 22.7% | 44.1% | 46.5% | 44.8% | 39.3% | |
| Changes by years, y/y, % | -7pp | -10pp | +11pp | +15pp | +13pp | |||
| Changes by quarters, q/q, % | +6pp | -15pp | +21pp | +2pp | -2pp | |||
